Publications

Filters

Publications Atlas Journal Article Research Report

Clinical and Practice Brain diseases Cancer and cancer screening Cardiovascular disease Chronic diseases and multimorbidity Diet and nutrition Endocrinology Environmental health Eye, ear, nose and throat disorders Gastroenterology Hematology Infectious diseases Injuries and accidents Internal medicine Kidney disease Lung health Musculoskeletal diseases and disorders Organ transplantation and donation Pharmacoepidemiology and drug safety Reproductive medicine Skin diseases and disorders

Healthcare Providers and Services Acute and emergency services End-of-life care Home and community care Long-term care and continuing care Maternity and neonatal care Mental health and addictions Nursing Pediatrics Pharmacy Primary care Public health Rehabilitation Surgery

People and Society Children and young people Health and healthcare inequality Indigenous Peoples Marginalized populations Older people Racialized communities Women or gender-based research

Research and Methods Data science Decision science Epidemiology Health economics Health services research Implementation science and knowledge translation Policy and program evaluation Statistics Trials

From

ICES Central ICES McMaster ICES North ICES Queen's ICES UofT ICES uOttawa ICES Western

Cancer Cardiovascular Chronic Disease & Pharmacotherapy Kidney, Dialysis & Transplantation Life Stage Mental Health & Addictions Populations & Public Health Primary Care & Health Systems

Showing 1-10 of 29

Journal Article

19/02/2024

A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection

Naveed Z, Chu C, Tadrous M, Veroniki AA, Li J, Rouleau I, Febriani Y, Calzavara A, Buchan S, Nasreen S, Schwartz KL, Wilton J, Seo CY, Thampi N, Wilson S, Naus M, De Serres G, Janjua NZ, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network investigators. Heliyon. 2024; Feb 19 [Epub ahead of print].

Journal Article

15/02/2024

Indirect impact of childhood 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian older adults: a Canadian Immunization Research Network (CIRN) retrospective observational study

Nasreen S, Wang J, Marra F, Kwong JC, McGeer A, Sadarangani M, Wilson SE, Fadel SA. Thorax. 2024; Feb 15 [Epub ahead of print].

Journal Article

24/11/2023

Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults

Lee N, Nguyen L, Austin PC, Brown KA, Grewal R, Buchan SA, Nasreen S, Gubbay J, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC. Clin Infect Dis. 2024; Nov 24 {Epub ahead of print].

Journal Article

23/10/2023

Newborn and early infant outcomes following maternal COVID-19 vaccination during pregnancy

Jorgensen S, Drover S, Fell D, Austin P, D’Souza R, Guttmann A, Buchan S, Wilson S, Nasreen S, Schwartz K, Tadrous M, Wilson K, Kwong J. JAMA Pediatr. 2023; Oct 23 [Epub ahead of print].

Journal Article

05/10/2023

Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study

Grewal R, Buchan SA, Nguyen L, Nasreen S, Austin PC, Brown KA, Gubbay J, Lee N, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC. J Infect Dis. 2023; Oct 5 [Epub ahead of print].

Journal Article

07/03/2023

Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes

Grewal R, Nguyen L, Buchan SA, Wilson SE, Nasreen S, Austin PC, Brown KA, Fell DB, Gubbay JB, Schwartz KL, Tadrous M, Wilson K, Kwong JC. Nat Commun. 2023; 14(1):1273. Epub 2023 Mar 7.

Journal Article

03/03/2023

COVID-19 vaccine effectiveness against Omicron infection and hospitalization

Piché-Renaud PP, Swayze S, Buchan SA, Wilson SE, Austin PC, Morris SK, Nasreen S, Schwartz KL, Tadrous M, Thampi N, Wilson K, KwongJC; Immunization Research Network (CIRN) Provincial Collaborative Investigators. Pediatrics. 2023; Mar 3 [Epub ahead of print].

Journal Article

27/02/2023

Myocarditis or pericarditis events after BNT162b2 vaccination in individuals aged 12 to 17 years in Ontario, Canada

Buchan SA, Alley S, Seo CY, Johnson C, Kwong JC, Nasreen S, Thampi N, Lu D, Harris TM, Calzavara A, Wilson SE. JAMA Pediatr. 2023; 177(4):410-8. Epub 2023 Feb 27.

Journal Article

03/12/2022

Effectiveness and duration of protection of a fourth dose of Coronavirus disease 2019 messenger RNA vaccine among long-term care residents in Ontario, Canada

Grewal R, Nguyen L, Buchan SA, Wilson SE, Costa AP, Kwong JC. J Infect Dis. 2023; 227(8):977–80. Epub 2022 Dec 3.

Journal Article

22/09/2022

Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes

Buchan SA, Chung H, Brown KA, Austin PC, Fell DB, Gubbay JB, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong JC. JAMA Netw Open. 2022; 5(9):e2232760. Epub 2022 Sep 22.

1 2 3 Next »

Publications

Filters

Resource Type

Topic

Date

ICES Scientists

ICES Site

Research Program

A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection

Indirect impact of childhood 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian older adults: a Canadian Immunization Research Network (CIRN) retrospective observational study

Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults

Newborn and early infant outcomes following maternal COVID-19 vaccination during pregnancy

Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study

Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes

COVID-19 vaccine effectiveness against Omicron infection and hospitalization

Myocarditis or pericarditis events after BNT162b2 vaccination in individuals aged 12 to 17 years in Ontario, Canada

Effectiveness and duration of protection of a fourth dose of Coronavirus disease 2019 messenger RNA vaccine among long-term care residents in Ontario, Canada

Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes